Top Biotechnology companies in the world by Net Income Margin

This ranking features the top 1,273 Biotechnology companies in the world ranked by Net Income Margin, averaging a Net Income Margin of -1,582,771.94%, for January 15, 2025.

Global

Biotechnology

#	Name	Net Income Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	94,684.72%	Sept. 30, 2024	USD 12.74	-6.60%	United States
2	Agri-tech (India) Limited 2 AGRITECH.NS	6,277.19%	March 31, 2024	USD 2.09	5.36%	India
3	Roivant Sciences Ltd. 3 ROIV	3,484.86%	March 31, 2024	USD 10.94	1.86%	United Kingdom
4	Eledon Pharmaceuticals, Inc. 4 ELDN	2,168.39%	Sept. 30, 2024	USD 3.71	-4.63%	United States
5	Agios Pharmaceuticals, Inc. 5 AGIO	2,051.38%	Sept. 30, 2024	USD 33.32	-2.86%	United States
6	Immuneering Corporation 6 IMRX	1,085.06%	Sept. 30, 2023	USD 1.95	-2.99%	United States
7	Shandong Oriental Ocean Sci-Tech Co., Ltd. 7 002086.SZ	400.15%	Dec. 31, 2023	USD 0.36	6.46%	China
8	RedHill Biopharma Ltd. 8 RDHL	367.19%	Dec. 31, 2023	USD 5.51	-1.08%	Israel
9	Oncimmune Holdings plc 9 ONC.L	356.25%	Aug. 31, 2023	USD 0.16	-0.68%	United Kingdom
10	Pharmena S.A. 10 PHR.WA	294.21%	Dec. 31, 2023	USD 1.01	1.23%	Poland
11	TaiGen Biopharmaceuticals Holdings Limited 11 4157.TWO	111.04%	Dec. 31, 2023	USD 0.32	0.12%	Taiwan
12	Formycon AG 12 FYB.DE	97.55%	Dec. 31, 2023	USD 60.50	-1.24%	Germany
13	Galapagos NV 13 GLPG.AS	88.31%	Dec. 31, 2023	USD 24.20	-0.41%	Belgium
14	L&C Bio Co., Ltd 14 290650.KQ	70.22%	Dec. 31, 2023	USD 16.30	-3.69%	South Korea
15	Imeik Technology Development Co.,Ltd. 15 300896.SZ	64.77%	Dec. 31, 2023	USD 23.99	3.90%	China
16	Bioventix PLC 16 BVXP.L	59.51%	June 30, 2024	USD 39.06	2.49%	United Kingdom
17	Origin Agritech Limited 17 SEED	59.30%	Sept. 30, 2023	USD 2.00	0.50%	China
18	Protagonist Therapeutics, Inc. 18 PTGX	52.76%	Sept. 30, 2024	USD 36.67	-1.26%	United States
19	Royalty Pharma plc 19 RPRX	50.54%	Sept. 30, 2024	USD 30.03	0.13%	United States
20	SIGA Technologies, Inc. 20 SIGA	49.33%	Sept. 30, 2024	USD 6.33	4.46%	United States
21	Yantai Zhenghai Biotechnology Co., Ltd. 21 300653.SZ	46.16%	Dec. 31, 2023	USD 2.82	2.48%	China
22	ORIENT BIO Inc. 22 002630.KS	45.96%	March 31, 2024	USD 1.22	1.14%	South Korea
23	Shanghai Yizhong Pharmaceutical Co., Ltd. 23 688091.SS	44.84%	Dec. 31, 2023	USD 4.94	3.02%	China
24	Akeso, Inc. 24 9926.HK	44.81%	Dec. 31, 2023	USD 7.28	2.32%	China
25	Beijing Succeeder Technology Inc. 25 688338.SS	42.44%	Dec. 31, 2023	USD 3.27	2.18%	China
26	Shenzhen New Industries Biomedical Engineering Co., Ltd. 26 300832.SZ	42.08%	Dec. 31, 2023	USD 8.51	2.10%	China
27	Shanghai MicroPort Endovascular MedTech Co., Ltd. 27 688016.SS	41.90%	Dec. 31, 2023	USD 15.35	4.46%	China
28	Bonesupport Holding AB (publ) 28 BONEX.ST	41.45%	Dec. 31, 2023	USD 32.97	-0.61%	Sweden
29	Halozyme Therapeutics, Inc. 29 HALO	41.43%	Sept. 30, 2024	USD 53.83	-0.57%	United States
30	Giant Biogene Holding Co., Ltd. 30 2367.HK	41.19%	Dec. 31, 2023	USD 6.64	6.03%	China
31	Beijing SL Pharmaceutical Co., Ltd. 31 002038.SZ	40.92%	Dec. 31, 2023	USD 1.04	1.87%	China
32	Clinuvel Pharmaceuticals Limited 32 CUV.AX	40.41%	June 30, 2024	USD 7.32	6.16%	Australia
33	United Therapeutics Corporation 33 UTHR	40.31%	Sept. 30, 2024	USD 364.70	0.50%	United States
34	G&E Herbal Biotechnology Co., Ltd. 34 4911.TWO	39.90%	Dec. 31, 2023	USD 1.63	0.49%
35	Jenkem Technology Co., Ltd. 35 688356.SS	39.62%	Dec. 31, 2023	USD 7.16	2.79%	China
36	Genovis AB (publ.) 36 GENO.ST	38.87%	Dec. 31, 2023	USD 2.09	-2.04%	Sweden
37	Tonghua Dongbao Pharmaceutical Co., Ltd. 37 600867.SS	37.97%	Dec. 31, 2023	USD 1.05	3.24%	China
38	Shionogi & Co., Ltd. 38 4507.T	37.24%	March 31, 2024	USD 14.22	-0.40%	Japan
39	BioArctic AB (publ) 39 BIOA-B.ST	37.22%	Dec. 31, 2023	USD 17.87	3.09%	Sweden
40	Wuhan Keqian Biology Co.,Ltd 40 688526.SS	37.21%	Dec. 31, 2023	USD 1.78	1.80%	China
41	Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. 41 300357.SZ	36.57%	Dec. 31, 2023	USD 2.64	3.21%	China
42	Sansure Biotech Inc. 42 688289.SS	36.12%	Dec. 31, 2023	USD 2.80	1.19%	China
43	PharmaEngine, Inc. 43 4162.TWO	35.78%	Dec. 31, 2023	USD 2.91	-0.09%	Taiwan
44	Hualan Biological Bacterin Inc. 44 301207.SZ	35.68%	Dec. 31, 2023	USD 2.46	5.25%	China
45	Mizuho Medy Co.,Ltd. 45 4595.T	34.34%	Dec. 31, 2023	USD 9.59	-1.93%	Japan
46	Regeneron Pharmaceuticals, Inc. 46 REGN	33.61%	Sept. 30, 2024	USD 690.87	-3.63%	United States
47	ChemoMetec A/S 47 CHEMM.CO	33.41%	June 30, 2024	USD 70.50	0.61%	Denmark
48	Chemclin Diagnostics Co., Ltd. 48 688468.SS	33.09%	Dec. 31, 2023	USD 0.92	3.55%	China
49	Osang Healthcare Co.,Ltd 49 036220.KQ	32.72%	Dec. 31, 2023	USD 11.90	21.74%	South Korea
50	Chengdu Kanghua Biological Products Co., Ltd. 50 300841.SZ	32.28%	Dec. 31, 2023	USD 7.13	3.78%	China

1 2 3 4 … 26

Frequently Asked Questions

Which Biotechnology company has the highest Net Income Margin ?

The Biotechnology company with the highest Net Income Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 94,684.72%.
Which Biotechnology company has the lowest Net Income Margin ?

The Biotechnology company with the lowest Net Income Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,956,524,900.00%.

What are the top 10 Biotechnology companies by Net Income Margin ?

The top 10 Biotechnology companies the Global by Net Income Margin are Inhibrx Biosciences, Inc., Agri-tech (India) Limited, Roivant Sciences Ltd., Eledon Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Immuneering Corporation, Shandong Oriental Ocean Sci-Tech Co., Ltd., RedHill Biopharma Ltd., Oncimmune Holdings plc and Pharmena S.A..
What are the bottom 10 Biotechnology companies by Net Income Margin ?

The bottom 10 Biotechnology companies by Net Income Margin are Inhibikase Therapeutics, Inc., Molecure S.A., ZyVersa Therapeutics, Inc., Inovio Pharmaceuticals, Inc., BrightPath Biotherapeutics Co., Ltd., Genomtec S.A., Summit Therapeutics Inc., Allogene Therapeutics, Inc., Forte Biosciences, Inc. and OncoZenge AB (publ).